Tae-Hwan Kwon Selected Research

Tae-Hwan Kwon Research Topics

Disease

17	Nephrogenic Diabetes Insipidus 01/2020 - 12/2003
12	Polyuria 01/2018 - 01/2002
9	Neoplasms (Cancer) 05/2022 - 01/2007
8	Ureteral Obstruction 01/2019 - 11/2003
6	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2011
6	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 12/2003
5	Fibrosis (Cirrhosis) 05/2023 - 11/2005
5	Acidosis 01/2014 - 03/2003
4	Ischemia 01/2021 - 08/2004
3	Inflammation (Inflammations) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2016
3	Mood Disorders (Mood Disorder) 01/2018 - 02/2010
3	Chronic Renal Insufficiency 07/2014 - 11/2010
3	Heart Failure 09/2013 - 01/2002
3	Diabetes Insipidus 06/2007 - 05/2005
3	Hypercalcemia (Milk Alkali Syndrome) 03/2004 - 01/2002
2	Kidney Diseases (Kidney Disease) 01/2021 - 11/2018
2	Sepsis (Septicemia) 11/2020 - 08/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2019
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2013 - 05/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013 - 11/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2013 - 04/2005
2	Azotemia 11/2010 - 04/2005
2	Shock 11/2010 - 12/2003
2	Proteinuria 11/2010 - 05/2004
2	Bone Resorption 05/2010 - 02/2009
2	Brain Ischemia (Cerebral Ischemia) 11/2008 - 10/2007
2	Ascites 11/2005 - 05/2004
2	Hypertrophy 04/2005 - 01/2004
1	Endotoxemia 11/2020
1	Hemorrhage 11/2020
1	Body Weight (Weight, Body) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Hypercholesterolemia 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

16	LithiumIBA 01/2020 - 12/2003
13	SodiumIBA 09/2015 - 03/2003
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
8	Aquaporin 2IBA 06/2019 - 01/2004
8	AldosteroneIBA 01/2018 - 12/2002
8	Aquaporins (Water Channels)IBA 10/2016 - 12/2002
6	Aquaporin 5IBA 05/2022 - 01/2011
4	Therapeutic UsesIBA 01/2021 - 01/2019
4	Peptides (Polypeptides)IBA 01/2020 - 01/2007
4	Vasopressins (Vasopressin)IBA 09/2015 - 01/2002
4	Messenger RNA (mRNA)IBA 10/2011 - 01/2004
3	CytokinesIBA 11/2020 - 06/2014
3	EnzymesIBA 01/2020 - 12/2007
3	Dinoprostone (PGE2)FDA Link 01/2019 - 05/2005
3	Tamoxifen FDA LinkGeneric 01/2019 - 01/2018
3	CreatinineIBA 07/2014 - 12/2003
3	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2011 - 06/2007
3	salicylhydroxamic acid (SHAM)IBA 11/2010 - 12/2003
3	Adenosine Triphosphatases (ATPase)IBA 02/2009 - 01/2004
3	Fluorescein (Funduscein)FDA LinkGeneric 11/2008 - 01/2007
3	Epithelial Sodium ChannelsIBA 05/2008 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2011
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 10/2008
2	ChemokinesIBA 07/2014 - 06/2014
2	AcidsIBA 01/2012 - 08/2009
2	SymportersIBA 05/2010 - 11/2005
2	Angiotensin IIIBA 12/2009 - 04/2005
2	Hormones (Hormone)IBA 05/2008 - 02/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2007 - 09/2003
2	Erythropoietin FDA Link 05/2007 - 08/2004
2	alpha-MSHIBA 02/2006 - 08/2004
2	Vitamin D FDA LinkGeneric 12/2002 - 01/2002
1	fisetinIBA 05/2023
1	FlavonoidsIBA 05/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	theasinensin AIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	PolymersIBA 01/2021
1	allithiamineIBA 11/2020
1	Thiamine (Aneurin)FDA Link 11/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	Myelin Basic ProteinIBA 01/2020
1	etomoxirIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	TransferasesIBA 01/2020
1	CollagenIBA 01/2019
1	CholesterolIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	butaprostIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Xanthine OxidaseIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Febuxostat FDA Link 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2018
1	SuspensionsIBA 11/2018
1	Bile Acids and Salts (Bile Acids)IBA 11/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2007
2	Intravenous Administration 01/2021 - 11/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021